1-1 of 1
Schetelig Johannes, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Gemtuzumab Ozogamicin as Part of Reduced-Intensity Conditioning in Patients with Relapsed or Refractory Acute Myeloid Leukemia - Results of a Phase I/II Trial.

Martin Bornhaeuser, MD, Thomas Illmer, MD, Platzbecker Uwe, MD, Ordemann Rainer, MD, Schetelig Johannes, MD, Schaich Markus, MD, Kiani Alexander, MD, Schuler Ulrich, MD, Ehninger Gerhard, MD
Journal: Blood
Blood (2007) 110 (11): 1997.
https://doi.org/10.1182/blood.V110.11.1997.1997
Published: 2007